Heyman Richard A.
Reporting owner on Forms 3, 4 and 5, CIK 1584759.
Heyman Richard A. reported on 1 issuer in 1 filing, the latest a Form 4 filed 2026-10-02.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| Oric Pharmaceuticals, Inc. CIK 1796280 | director | 1 | 2026-10-02 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| Oric Pharmaceuticals, Inc. Common Stock | 2026-10-01 | M exercised | +3,500 | $1.6 | 41,800 | Form 4 |
| Oric Pharmaceuticals, Inc. Common Stock | 2026-10-01 | S sold | -3,500 | $12.9141 | 38,300 | Form 4 |
| Oric Pharmaceuticals, Inc. Common Stock | 2026-10-01 | S sold | -3,200 | $12.9141 | 203,472 | Form 4 |
| Oric Pharmaceuticals, Inc. Stock Option (right to buy), derivative | 2026-10-01 | M exercised | -3,500 | $0 | 26,700 | Form 4 |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| Form 4 0001584759-26-000017 | Oric Pharmaceuticals, Inc. | 2026-10-02 |